Stay updated on Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial

Sign up to get notified when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Footer revision tag updated to v3.3.4, replacing the previous v3.3.3 tag. No other page content or study details appear to be changed.
    Difference
    0.0%
    Check dated 2026-01-14T01:22:45.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The Locations section is expanded to include multiple Chinese sites (Beijing Municipality, Heilongjiang, Henan, Hubei, Hunan, Jiangsu, Jiangxi, Jilin, Liaoning, Ningxia, Shanxi, Sichuan, Tianjin Municipality, Zhejiang). Individual province location subsections were removed or reorganized, consolidating site information under the new Locations heading.
    Difference
    2%
    Check dated 2025-12-23T08:42:58.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Site revision updated from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-24T17:41:12.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The funding/operating-status notice banner was removed. The study details, locations, and eligibility criteria remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T17:22:35.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page. The content appears unchanged between the two screenshots.
    Difference
    0.4%
    Check dated 2025-11-03T11:38:52.000Z thumbnail image
  8. Check
    108 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.
    Difference
    5%
    Check dated 2025-10-05T17:19:35.000Z thumbnail image

Stay in the know with updates to Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.